Bannayan–Riley–Ruvalcaba syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Bannayan–Riley–Ruvalcaba syndrome | |
|---|---|
| Synonyms | Bannayan–Zonana syndrome, Riley–Smith syndrome, Ruvalcaba–Myhre–Smith syndrome |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Macrocephaly, lipomas, hemangiomas, pigmented macules on the glans penis |
| Complications | N/A |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the PTEN gene |
| Risks | |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Cowden syndrome, Proteus syndrome, Neurofibromatosis type I |
| Prevention | |
| Treatment | Symptomatic treatment, surgical removal of lipomas |
| Medication | |
| Prognosis | Generally good with management |
| Frequency | Rare |
| Deaths | |


Bannayan–Riley–Ruvalcaba syndrome (BRRS) is a rare overgrowth syndrome and hamartomatous disorder with a wide spectrum of phenotypic expression. It is characterized by macrocephaly, intestinal polyposis, lipomas, and pigmented macules of the glans penis.
Signs and Symptoms[edit]
BRRS is characterized by a variety of symptoms, including macrocephaly, intestinal polyposis, lipomas, and pigmented macules of the glans penis. Other symptoms may include developmental delay, thyroid problems, and an increased risk of certain types of cancer.
Causes[edit]
BRRS is caused by mutations in the PTEN gene. This gene provides instructions for making a protein that is involved in cell signaling and regulation of cell growth. Mutations in the PTEN gene disrupt the protein's function, leading to uncontrolled cell growth and division.
Diagnosis[edit]
Diagnosis of BRRS is based on clinical features and can be confirmed by genetic testing for mutations in the PTEN gene.
Treatment[edit]
Treatment for BRRS is symptomatic and supportive. It may include regular monitoring for the development of tumors and other complications.
Prognosis[edit]
The prognosis for individuals with BRRS varies. Some individuals may have mild symptoms and a normal lifespan, while others may have severe complications and a shortened lifespan.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
